Evaluation on biocompatibility of biomedical polyurethanes with different hard segment contents
Dai-Wei MA, Rong ZHU, Yi-Yu WANG, Zong-Rui ZHANG, Xin-Yu WANG
Evaluation on biocompatibility of biomedical polyurethanes with different hard segment contents
In this paper, polyurethane (PU) materials with different contents of hard segment (20%, 25%, 30%) were prepared based on hexamethylene diisocyanate and polycarbonate diols by solution polymerization. The obtained polycarbonate-urethane (PCU) elastomers were characterized by very good hydrophobic property and excellent resistance to hydrolysis. Hemolysis, recalification time and platelet-rich plasma adhesion were used to evaluate the blood compatibility of the materials. L929 cells cultured with leach liquor of these PU membranes were selected to perform the cytotoxicity experiments. The results indicate that the hemolysis rates of PU membranes are all less than 5%, which can meet the requirement of the national standards for biomaterials. However, compared with 20% and 30% groups, the recalification time of the sample containing 25% hard segment is longer, while the number of platelet adhesion is less. Additionally, cells cultured in the leach liquor of PU membranes with 25% hard segment proliferated relatively more thriving, meaning that this proportion of the material has the lowest cytotoxicity.
polyurethane (PU) / hydrolytic stability / blood compatibility / cytotoxicity
[1] |
Chen L, Han D, Jiang L. On improving blood compatibility: from bioinspired to synthetic design and fabrication of biointerfacial topography at micro/nano scales. Colloids and Surfaces B: Biointerfaces, 2011, 85(1): 2–7
|
[2] |
Ratner B D. The catastrophe revisited: blood compatibility in the 21st Century. Biomaterials, 2007, 28(34): 5144–5147
|
[3] |
Gorbet M B, Sefton M V. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials, 2004, 25(26): 5681–5703
|
[4] |
Mao C, Qiu Y, Sang H,
|
[5] |
Szycher M, Siciliano A A, Reed A M. Polyurethane elastomers in medicine. Polymeric. Biomaterials. New York: Marcel Dekker, 1994, 233–244
|
[6] |
Simmons A, Hyvarinen J, Odell R A,
|
[7] |
Baumann H, Richter A, Klemm D,
|
[8] |
Bernacca G M, Gulbransen M J, Wilkinson R,
|
[9] |
Jo H Y, Jung W K, Kim S K. Purification and characterization of a novel anticoagulant peptide from marine echiuroid worm, Urechis unicinctus. Process Biochemistry, 2008, 43(2): 179–184
|
[10] |
Laredo J, Xue L, Husak V A,
|
[11] |
Sawada S, Iwasaki Y, Nakabayashi N,
|
[12] |
Jia R P, Zong A X, He X Y,
|
[13] |
Yan X, Chen J, Yang J,
|
[14] |
Fang H, Wei J, Yu Y. In vivo studies of endotoxin removal by lysine-cellulose adsorbents. Biomaterials, 2004, 25(23): 5433–5440
|
[15] |
Kuran W, Sobczak M, Listos T,
|
[16] |
Zhang J, Hu C P. Synthesis, characterization and mechanical properties of polyester-based aliphatic polyurethane elastomers containing hyperbranched polyester segments. European Polymer Journal, 2008, 44(11): 3708–3714
|
[17] |
Sagnella S, Mai-Ngam K. Chitosan based surfactant polymers designed to improve blood compatibility on biomaterials. Colloids and Surfaces B: Biointerfaces, 2005, 42(2): 147–155
|
[18] |
American Society for Testing and Materials. ASTM F 756-00, Standard Practices for Assessment of Haemolytic Properties of Materials, 2000
|
[19] |
Xue J, Zhao W, Nie S,
|
[20] |
Yuse K, Guiffard B, Belouadah R,
|
/
〈 | 〉 |